ANDA 202496

RITEDOSE CORP

FDA Drug Application

Application #202496

Application Sponsors

ANDA 202496

RITEDOSE CORP

Marketing Status

• Prescription: 001

Application Products

001

SOLUTION;INHALATION

EQ 0.083% BASE;0.017%

0

ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE

ALBUTEROL SULFATE; IPRATROPIUM BROMIDE

FDA Submissions

UNKNOWN;

ORIG

1

AP

2012-10-01

Submissions Property Types

ORIG

1

Null

17

TE Codes

001

Prescription

AN

CDER Filings

RITEDOSE CORP

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 202496
            [companyName] => RITEDOSE CORP
            [docInserts] => ["",""]
            [products] => [{"drugName":"ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE","activeIngredients":"ALBUTEROL SULFATE; IPRATROPIUM BROMIDE","strength":"EQ 0.083% BASE;0.017%","dosageForm":"SOLUTION;INHALATION","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"10\/01\/2012","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2012-10-01
        )

)